Global stem cell research pioneering ethical, effective, and safe cord blood therapies51-200 Employees
- Early StageStartup in initial stages
People at BHI Therapeutic Sciences
BHI Therapeutic Sciences, Inc. (BHITS) conducts research to support commercialization of stem cell technology to support regenerative medicine. Stem cells are a multipotent human cell that have the potential to support regenerative repair of the human body. BHITS is developing a stem cell technology to support regenerative repair with the intent of avoiding surgery as a final option. BHITS believes stem cells possess the potential to treat various diseases, to extend lifespans and to improve the quality of life for certain patients.
Brian Mehling
Board Member, Chief Medical Officer
Eddie Amarante
Background
- BHI Therapeutic Sciences
Founder
- Blue Horizon International
Board Member
- BHI Therapeutic Sciences
Board Member
Founder BHITherapeutic Sciences, Mehling Orthopedics and Industrial Motion Picture
Katarina Novakova
Klara Doert
My Goal is to offer my international background as Experienced, Educated, and Ambitious
Business Development Management Professional to develop the...
Michael Platt, Ph.D.
A
Michael A Kelly, M.D
A
Joseph Feldman, M.D FACEP
A